MYGN Financial Facts

Cost of molecular diagnostic testing: 22.76M
Interest income: 1.33M
See Full Income Statement

Accumulated other comprehensive income: 506K
Total liabilities: 80.71M
See Full Balance Sheet

Myriad Genetics Inc. (MYGN) Earnings

  |   Expand Research on MYGN
Next EPS Date 5/2/14 *Est. EPS Growth Rate +57.1% *Last Qtr.
Average EPS % Beat Rate +30.6% Revenue Growth Rate +36.9% *Last Qtr.
Average % Move 1-Wk after EPS +0.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
11/2/10 Q111 $0.24$0.23 +$0.01N/AN/A +92.7% Details
5/3/11 Q311 $0.31$0.25 +$0.06$102.4M$98.11M +77.9% Details
1/27/11 Q211 $0.26$0.26 $0.00$100.4M$98.84M +69.9% Details
11/1/11 Q112 $0.29$0.28 +$0.01$110.5M$106.49M = +86.8% Details
8/9/11 Q411 $0.30$0.29 +$0.01$107.4M$104.43M = +100.9% Details
1/31/12 Q212 $0.33$0.31 +$0.02$122.8M$115.28M = +60.5% Details
11/5/12 Q113 $0.36$0.32 +$0.04$133.44M$129.43M +41.4% Details
5/1/12 Q112 $0.34$0.32 +$0.02$129.8M$119.2M = +45.9% Details